Registration

is now open!

Fees

Please refer to the World Bank Data to determine what classification your country falls under.

WHA members are eligible for one complimentary registration per organisation – learn more here.

Industry attendees, please email summit@worldhepatitisalliance.org to discuss registration rates.

If you are a member of the media or press, kindly contact contact@worldhepatitisalliance.org to request your media registration.

What’s included in your booking

In-person

  • Full access to the three-day conference, including main plenary, workshops and symposiums.
  • Simultaneous translation in French and Spanish available in pre-determined sessions.
  • Extensive networking opportunities.
  • Meet with exhibitors and sponsors.
  • Access to the WHS 2024 virtual platform.
  • Lunch (served on days 1 and 2 in the on-site canteen).

Virtual

  • Livestreamed plenary sessions.
  • Access to pre-determined livestreamed breakout sessions.
  • Details of which sessions are included will be available later in the year.
  • Online networking opportunities.
  • Access to on-demand sessions.
  • Simultaneous translation in French and Spanish available in pre-determined sessions.

Registration deadlines

Standard registrations close 11:59pm (GMT) on 8 April, 2024.

On-site rates will apply to new registrations during the Summit, 9-11 April, 2024.

There is no deadline for virtual attendees.

Policies

Review our cancellation policy and privacy policy. If you have any questions about your registration, please contact WHS@serenevents.com.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

The role of decentralised and community-led services in accelerating progress towards elimination.

Role of harm reduction.